Arcutis Biotherapeutics (ARQT) Other Gross PP&E Adjustments: 2020-2025
Historic Other Gross PP&E Adjustments for Arcutis Biotherapeutics (ARQT) over the last 6 years, with Sep 2025 value amounting to -$4.6 million.
- Arcutis Biotherapeutics' Other Gross PP&E Adjustments fell 121.70% to -$4.6 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$22.2 million, marking a year-over-year decrease of 48.26%. This contributed to the annual value of -$14.1 million for FY2024, which is 65.64% down from last year.
- According to the latest figures from Q3 2025, Arcutis Biotherapeutics' Other Gross PP&E Adjustments is -$4.6 million, which was down 164.29% from -$1.7 million recorded in Q2 2025.
- In the past 5 years, Arcutis Biotherapeutics' Other Gross PP&E Adjustments ranged from a high of $818,000 in Q3 2023 and a low of -$14.1 million during Q4 2024.
- For the 3-year period, Arcutis Biotherapeutics' Other Gross PP&E Adjustments averaged around -$3.3 million, with its median value being -$2.1 million (2024).
- In the last 5 years, Arcutis Biotherapeutics' Other Gross PP&E Adjustments surged by 1,378.12% in 2023 and then plummeted by 1,215.27% in 2024.
- Arcutis Biotherapeutics' Other Gross PP&E Adjustments (Quarterly) stood at -$4.4 million in 2021, then plummeted by 71.60% to -$7.5 million in 2022, then fell by 13.51% to -$8.5 million in 2023, then tumbled by 65.64% to -$14.1 million in 2024, then tumbled by 121.70% to -$4.6 million in 2025.
- Its last three reported values are -$4.6 million in Q3 2025, -$1.7 million for Q2 2025, and -$1.8 million during Q1 2025.